About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Soligenix’s Drug Shows Potential to Treat Oral Mucositis in Phase 2 Trial

by Reshma Anand on December 17, 2015 at 2:58 PM
Font : A-A+

Soligenix’s Drug Shows Potential to Treat Oral Mucositis in Phase 2 Trial

New Jersey-based biopharmaceutical company, Soligenix has revealed that its developing drug has showed positive results against oral mucositis in Phase 2 clinical trial.

The drug called SGX942 is a first-in-class innate defense regulator (IDR) which at a dose of 1.5 mg/kg has successfully reduced the median duration of severe oral mucositis by 50% in all patients and by 67% in patients receiving the most aggressive Chemo-Radiation Therapy (CRT).

Advertisement


Oral Mucositis is a devastating side effect of CRT, which is used for the treatment of head and neck cancers. Currently, there is no cure for this disease and SGX942 is the first Innate Defense Regulator in development for oral mucositis.

The phase 2 clinical trial was conducted in 111 patients undergoing CRT for head and neck cancer. They were grouped across three SGX942 dose groups and a placebo group. The results were found positive in the 1.5 mg/kg treatment group. The drug reduced the median duration of severe oral mucositis by 50%, from 18 days to nine days.
Advertisement

Patients receiving the most aggressive CRT in this dose group had even more striking reductions in their median duration of severe oral mucositis of 67%, from 30 days to 10 days.

"We are extremely pleased with the findings from the first Phase 2 study of SGX942. The study met all of its objectives of defining the best dose, the most appropriate clinical endpoint, and patient population to use in future pivotal trials," said Richard Straube, chief medical officer.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
Test Your Knowledge on Lung Transplantation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Dental Check-Up 

Most Popular on Medindia

Noscaphene (Noscapine) Post-Nasal Drip Blood - Sugar Chart Nutam (400mg) (Piracetam) Drug Side Effects Calculator Sinopril (2mg) (Lacidipine) A-Z Drug Brands in India Hearing Loss Calculator Blood Donation - Recipients Drug Interaction Checker
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use